Statutory Profit Doesn't Reflect How Good Phibro Animal Health's (NASDAQ:PAHC) Earnings Are

Phibro Animal Health Corporation's (NASDAQ:PAHC) strong earnings report was rewarded with a positive stock price move. Our analysis found some more factors that we think are good for shareholders.

This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.

How Do Unusual Items Influence Profit?

Importantly, our data indicates that Phibro Animal Health's profit was reduced by US$22m, due to unusual items, over the last year. While deductions due to unusual items are disappointing in the first instance, there is a silver lining. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And that's hardly a surprise given these line items are considered unusual. If Phibro Animal Health doesn't see those unusual expenses repeat, then all else being equal we'd expect its profit to increase over the coming year.

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

Our Take On Phibro Animal Health's Profit Performance

Unusual items (expenses) detracted from Phibro Animal Health's earnings over the last year, but we might see an improvement next year. Based on this observation, we consider it likely that Phibro Animal Health's statutory profit actually understates its earnings potential! And on top of that, its earnings per share have grown at an extremely impressive rate over the last year. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. If you'd like to know more about Phibro Animal Health as a business, it's important to be aware of any risks it's facing. To that end, you should learn about the 2 warning signs we've spotted with Phibro Animal Health (including 1 which is a bit concerning).

Today we've zoomed in on a single data point to better understand the nature of Phibro Animal Health's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.